• Return to Headlines

96.3% Return Seen to Date on SmarTrend Array Biopharma Call (ARRY)

By Shiri Gupta

SmarTrend identified an Uptrend for Array Biopharma (NASDAQ:ARRY) on May 21st, 2019 at $24.38. In approximately 4 months, Array Biopharma has returned 96.27% as of today's recent price of $47.85.

In the past 52 weeks, shares of Array Biopharma have traded between a low of $12.56 and a high of $47.98 and are now at $47.85, which is 281% above that low price. Over the past week, the 200-day moving average (MA) has remained constant while the 50-day MA has remained constant.

Array BioPharma Inc. is a discovery research company, creates drug candidates. The Company provides drug discovery products and services to create, evaluate, and optimize potential drug candidates in collaboration with pharmaceutical and biotechnology companies.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Array Biopharma shares.

Log in and add Array Biopharma (ARRY) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights Array BioPharma

Ticker(s): ARRY